T-cell malignancies account for approximately 12% of all non-Hodgkin's lymphomas. With more than 30 identified subtypes of T-cell neoplasms, diagnosis can be difficult. We offer comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma. In addition, our hematopathology team has extensive experience with T-cell neoplasms and frequently provides consultations for clients around the globe.
T-cell lymphoma Test menu
Key testing
Highlights
Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.